| It is a physiological substance present normally in the body. It is one of the drug of choice for paroxysmal supraventricular tachycardia.
| Composition : | 6mg/2ml, 30mg/10ml | | Indications : | Treatment of PSVT. Diagnosis ofre-entrant atrial and ventricular tachycardia. | | Contraindications : | Various degrees of heart block, sicksinus syndrome and bronchial asthma . | | Safety Profile : | In patients of atrialflutter/fibrillation, in pregnancy used if absolute necessary. | | Adverse Effects : | Flushing, dyspnoea, nausea, lightheadedness, sweating, palpitation & heaviness in arms. | | Dosage : | Adults - initial dose of 3.5mg asrapid intravenous bolus, second dose is repeated after 2 mts, if firstdose fails to abort the attack of PSVT. It is given 6mg rapidlyintravenously, If attack still persists, give third dose of 12mg rapidlyintravenously. Additional or higher doses are not recommended. | | Purity : | Not less than 99%. |
|
 |
© Health Biotech Limited. All Rights Reserved (Terms of Use)
